Pepfect 2

General Information


DRACP ID  DRACP05795

Peptide Name   Pepfect 2

Sequence  MVTVLFRRLRIRRACGPPRVRV

Sequence Length  22

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Cancer targeted peptides Membrane-targeted Cell-penetrating peptides



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Stearylation

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C116H207N43O24S2

Absent amino acids  DEHKNQSWY

Common amino acids  R

Mass  302705

Pl  12.9

Basic residues  7

Acidic residues  0

Hydrophobic residues  9

Net charge  7

Boman Index  -6673

Hydrophobicity  9.55

Aliphatic Index  110.45

Half Life 
  Mammalian: 1 hour
  Yeast: 2 min
  E.coli: 2 min

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  3

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID US20140140929A1

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




Cppsite ID  3000

DRACP is developed by Dr.Zheng's team.